Aptevo Therapeutics Stock Quote APVO - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.421

Bid

0.3975

Ask

0.4267

Volume

513,760

0.39 Day's Range 0.4344

0.2848 52 Week Range 48.40

Market Cap

1.718M

Previous Close

0.4078

Open

0.39

Last Trade

500

0.421

(formt)

Last Trade Time

Financial Volume

$ 210,530

VWAP

0.409783

Average Volume (3m)

6,407,714

Shares Outstanding

4,080,169

Dividend Yield

PE Ratio

-0.10

Earnings Per Share (EPS)

-4.27

Revenue

Net Profit

-17.41M

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aptevotherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Aptevo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APVO. The last closing price for Aptevo Therapeutics was $0.41. Over the last year, Aptevo Therapeutics shares have traded in a share price range of $ 0.2848 to $ 48.40.

Aptevo Therapeutics currently has 4,080,169 shares outstanding. The market capitalization of Aptevo Therapeutics is $1.66 million. Aptevo Therapeutics has a price to earnings ratio (PE ratio) of -0.10.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0421	-9.09090909091	0.4631	0.548	0.3813	3232645	0.43409304	CS
4	0.0023	0.54931932171	0.4187	0.6559	0.2848	18701081	0.55931124	CS
12	-0.599	-58.7254901961	1.02	1.19	0.2848	6407714	0.56734629	CS
26	-6.5794	-93.9860579395	7.0004	10.8	0.2848	3422418	0.88458716	CS
52	-45.339	-99.0799825175	45.76	48.4	0.2848	1917805	2.33770624	CS
156	-907.299	-99.953620059	907.72	971.5156	0.2848	1051723	210.85176313	CS
260	-37.6786	-98.8950015223	38.0996	2640	0.2848	842802	281.61658886	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M